Journal of Geriatric Oncology
Publisher: Elsevier · ISSN 1879-4068 · 30 articles
- A pilot randomized controlled trial of the feasibility and safety of a combined Epigallocatechin-3-gallate (EGCG) and vitamin C nutraceutical in pre-frail and frail older cancer survivors: Results from the ReFOCUS1 trial
- Comment on “Transcutaneous auricular vagus nerve stimulation for prevention of postoperative cognitive dysfunction in older adults with gastrointestinal tumors: A randomized controlled trial”
- Cognitive impairment: Delirium and dementia for oncologists
- Age-related physiological changes and their implications for the management of older adults with cancer: A narrative review
- Patient education for older adults with cancer and their caregivers: A scoping review
- Managing patients with advanced non-small cell lung cancer alongside complex comorbidities and frailty: A consensus statement and implications for the United Kingdom health system
- Frailty and clinical outcomes in older adults with gynaecological malignancies: A systematic review and meta-analysis
- Geriatric assessment domains, frailty indices, and survival in older adults with breast cancer: a systematic review and meta-analysis
- Frailty as a predictor of chemotherapy-related outcomes in older adults with cancer: A systematic review and meta-analysis
- Loneliness trajectories and psychosocial, behavioral, and functional vulnerability among cancer survivors: A comparison of patients aged 50–64, 65–74, and ≥75 years
- Duration of depressive symptoms prior to a cancer diagnosis and post-cancer memory function and decline: A longitudinal analysis of the US Health and Retirement Study
- Frailty and home time loss after surgical resection for patients with non-metastatic pancreatic cancer
- Psychological resilience is associated with increased heterogeneity in the clinical aging phenotypes of patients with cancer
- Conversational artificial intelligence for geriatric screening: A mixed-methods feasibility study
- Validation of the CARG tool in prediction of chemotherapy completion and side effects in older adults with cancer: A retrospective cohort study
- Beyond age: The prognostic impact of frailty on in-hospital outcomes in chronic lymphocytic leukemia
- Reducing joint pain associated with aromatase inhibitor therapy and improving medication adherence in older breast cancer survivors through exercise and education: main results from the REJOIN randomized controlled pilot trial
- Implementation of geriatric assessment in oncology practice: A multicenter cross-sectional survey from French and Moroccan oncology practice settings
- Effectiveness of primary endocrine therapy in older adults with estrogen receptor-positive breast cancer: A real-world audit of a dedicated primary endocrine therapy clinic
- Implementing an electronic geriatric assessment platform for older U.S. veterans with cancer: A pilot study
- Evolution of geriatric oncology care in Morocco: Complete results of a pilot care pathway in the Northern region
- Low use of guideline-recommended treatment among Medicare Advantage and traditional Medicare beneficiaries with advanced lung cancer
- Factors associated with study participation among older patients with cancer: A retrospective analysis of the GOBI trial in Germany
- Geographical access to radiotherapy and surgical treatment selection in older women with HER2-positive and triple-negative breast cancer: A real-world exploratory study
- Beyond walking distance: Recognising functional vulnerability and supporting recovery after gastrointestinal cancer surgery
- Response to: Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia
- Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia
- Prediction model development in older patients with cancer: Practical guidance and key vigilance points
- Oncologist perspectives on a novel geriatric assessment tool for older adults with cancer - The Comprehensive Health Assessment for My Plan (CHAMP): A multimethod study
- Machine learning reveals pre-treatment deficit accumulation as a predictor of persistent cancer-related fatigue: The Thinking and Living with Cancer longitudinal cohort study